Lies&damnedlies, rather than a dividend cap valuation, another way of looking at it: If they grow overheads to $35m and are generating $180m revenue = $145m gross profit at 90% margin, so $130m profit before tax and ~$100m NPAT. What P/E ratio would be appropriate for a high growth high margin med device company? How long is a piece of string but the answer would start with at least a 2 in front of it. My guess is if they hit $180m its at least a $2b mkt cap company, which is about $1/sh..
IPD Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
